Archives

  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Sulfo-Cy7 NHS Ester: The Benchmark Sulfonated Near-Infrar...

    2026-01-29

    Sulfo-Cy7 NHS Ester: Benchmarking a Sulfonated Near-Infrared Fluorescent Dye for Advanced Biomolecule Labeling

    Principle Overview: What Sets Sulfo-Cy7 NHS Ester Apart?

    Sulfo-Cy7 NHS Ester is a state-of-the-art sulfonated near-infrared fluorescent dye optimized for covalently labeling primary amines in biomolecules, such as proteins, peptides, and membrane vesicles. Distinguished by its hydrophilicity and exceptional water solubility, this dye enables biomolecule conjugation without the need for organic co-solvents—a crucial advantage when working with delicate, denaturation-prone targets. The presence of sulfonate groups not only enhances solubility but also drastically reduces fluorescence quenching, a common pitfall in densely labeled biomolecules or vesicle preparations.

    With an excitation maximum at 750 nm and emission at 773 nm, Sulfo-Cy7 NHS Ester leverages the optical transparency window of biological tissues (tissue transparency imaging), facilitating deep, non-destructive imaging for both in vitro and in vivo applications. Its high extinction coefficient (240,600 M⁻¹cm⁻¹) and quantum yield (0.36) endow it with outstanding sensitivity, supporting quantitative imaging across a spectrum of research needs—including live cell and animal models.

    As highlighted in a recent mechanistic study on Clostridium difficile-derived membrane vesicles and fetal growth restriction, robust tracking of bacterial vesicles within mammalian tissues demands probes that combine strong signal intensity, low background, and excellent biocompatibility—criteria fulfilled by Sulfo-Cy7 NHS Ester.

    Step-by-Step Workflow: Optimized Labeling and Imaging with Sulfo-Cy7 NHS Ester

    1. Preparation and Handling

    • Storage: Store the dye at -20°C, protected from light and moisture. Open vials should be handled in low-light conditions to prevent photo-degradation.
    • Solubilization: Dissolve Sulfo-Cy7 NHS Ester immediately before use in water, DMSO, or DMF. For protein and vesicle labeling, high water solubility enables direct use in physiological buffers, eliminating the need for organic co-solvents and preserving biomolecule integrity.

    2. Biomolecule Conjugation Protocol

    1. Buffer Preparation: Use a pH 7.5–8.5 buffer (e.g., 100 mM sodium bicarbonate) to favor NHS-ester reactivity with primary amines.
    2. Dye Addition: Add Sulfo-Cy7 NHS Ester to your biomolecule solution at a typical dye-to-protein (or vesicle) molar ratio of 5:1 to 20:1, depending on the degree of labeling desired.
    3. Incubation: Incubate at room temperature for 30–60 minutes, shielded from light.
    4. Quenching and Purification: Quench unreacted NHS-ester with 50 mM Tris or glycine. Remove free dye using gel filtration, ultrafiltration, or dialysis.
    5. Characterization: Quantify labeling efficiency via absorbance at 750 nm; confirm retention of biomolecule function (e.g., enzymatic activity, vesicle integrity) by control assays.

    For membrane vesicle tracking, as demonstrated in this application-focused article, Sulfo-Cy7 NHS Ester provides high-contrast, quantitative in vivo imaging of vesicle trafficking and placental targeting, supporting mechanistic studies such as those investigating the impact of bacterial vesicles on fetal development.

    Advanced Applications: Sensitivity, Multiplexing, and Non-Destructive Imaging

    Labeling Delicate Proteins and Vesicles in Translational Research

    Sulfo-Cy7 NHS Ester’s hydrophilic profile is transformative for labeling labile proteins, fragile peptides, and lipid-rich membrane vesicles—targets that typically denature in the presence of organic solvents. This property enables efficient amino group labeling in aqueous media, preserving biological function and enabling direct use in downstream assays.

    • Quantitative Imaging: The dye’s excellent signal-to-noise ratio and reduced self-quenching facilitate accurate quantification of labeled species, even in complex biological matrices.
    • Live Cell and In Vivo Bioimaging: The near-infrared spectral window ensures minimal tissue autofluorescence and deep tissue penetration. This is crucial for applications such as live tracking of labeled vesicles or proteins in animal models, exemplified by the referenced FGR study, where vesicle trafficking and placental localization are monitored non-invasively.
    • Multiplexing Potential: Sulfo-Cy7 NHS Ester can be integrated into multicolor imaging panels with other fluorophores (e.g., Cy3, FITC, Cy5), enabling parallel tracking of different biomolecule populations.

    For comparative insights, this benchmarking study highlights Sulfo-Cy7 NHS Ester’s superior performance relative to less sulfonated analogs, especially in live tissue imaging and multiplexed workflows—contrasting with traditional dyes that often suffer from aggregation and rapid signal decay.

    Integration with Mechanistic and Translational Research

    The referenced npj Biofilms and Microbiomes article underlines the importance of sensitive, non-destructive fluorescent probes for tracking bacterial vesicles’ biodistribution and mechanistic effects in vivo. Sulfo-Cy7 NHS Ester’s high quantum yield and resistance to quenching proved essential for visualizing C. difficile-derived membrane vesicles as they trafficked to—and accumulated within—the placenta. This enabled researchers to elucidate how these vesicles impair trophoblast motility via the PPARγ/RXRα/ANGPTL4 axis, ultimately driving fetal growth restriction.

    Similarly, this review complements the above findings, emphasizing Sulfo-Cy7’s role as a fluorescent probe for live cell imaging and in translational workflows, particularly where protein and vesicle integrity are paramount.

    Troubleshooting and Optimization Tips

    Common Challenges and Solutions

    • Low Labeling Efficiency: Ensure fresh dye is used—old or improperly stored dye can hydrolyze, reducing reactivity. Always dissolve immediately before use and minimize light exposure.
    • Protein or Vesicle Aggregation: Leverage the dye’s water solubility by avoiding organic solvents. Use gentle mixing and avoid excessive dye:biomolecule ratios that may induce cross-linking.
    • Residual Free Dye Post-Purification: Employ size-exclusion columns or high-molecular-weight cut-off filters to efficiently separate labeled biomolecules from unreacted dye.
    • Signal Quenching or Instability: Sulfo-Cy7 NHS Ester is engineered to minimize self-quenching, but over-labeling can still cause signal loss. Empirically determine the optimal dye:biomolecule ratio for your system, starting at 5:1 and adjusting as needed.

    Best Practices for Long-Term Success

    • Use Labeled Biomolecules Promptly: While the dry dye is stable for up to 24 months at -20°C, conjugated solutions should be used within days to retain maximal fluorescence.
    • Maintain Shielding from Light: Conduct all labeling steps under subdued or red light; store both dye and labeled biomolecules in the dark.
    • Quality Controls: Always include unlabeled controls and, if possible, validate functional activity post-labeling (e.g., enzymatic assays, vesicle uptake tests).

    For comprehensive troubleshooting and workflow refinements, see this protocol-oriented resource, which details stepwise labeling, purification, and advanced troubleshooting for Sulfo-Cy7 NHS Ester and similar dyes.

    Future Outlook: Expanding Horizons in Bioimaging and Mechanistic Research

    As the demand for quantitative, high-sensitivity near-infrared fluorescent imaging grows—spanning from basic mechanistic studies to translational, clinically relevant investigations—Sulfo-Cy7 NHS Ester is poised to remain at the forefront of protein labeling dye technology. Its unique combination of hydrophilicity, minimized quenching, and compatibility with live tissues is accelerating discoveries in fields such as:

    • Microbiota-derived vesicle trafficking: Mapping the biodistribution and host-pathogen interactions of bacterial vesicles, as in the FGR model.
    • Targeted drug delivery: Tracking peptide, protein, or nanoparticle therapeutics in real-time within live organisms.
    • Multiplexed diagnostics: Simultaneous monitoring of multiple biomolecules in complex tissue environments.

    Ongoing advances in dye chemistry and conjugation protocols will further increase labeling efficiency and functional preservation, broadening the scope for Sulfo-Cy7 NHS Ester in both established and emerging research paradigms.

    For researchers seeking a reliable, high-performance Sulfo-Cy7 NHS Ester supplier, APExBIO stands out as a trusted partner, offering rigorous quality control and expert technical support for all your bioimaging needs.

    Conclusion

    Sulfo-Cy7 NHS Ester is redefining what is possible in near-infrared dye for bioimaging. Its unrivaled water solubility, minimized fluorescence quenching, and compatibility with delicate biomolecules empower researchers to push the frontiers of live cell and tissue imaging, quantitative tracking, and mechanistic discovery. Whether you’re mapping vesicle trafficking, interrogating protein interactions, or developing novel diagnostic tools, Sulfo-Cy7 NHS Ester—supplied by APExBIO—delivers the reliability and sensitivity your research demands.